Hedgehog Signaling Pathway
Showing 1 - 25 of 4,480
Esophageal Cancer Trial in Dallas (Itraconazole)
Active, not recruiting
- Esophageal Cancer
-
Dallas, TexasDallas VA Medical Center
Nov 2, 2021
Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)
Not yet recruiting
- Basal Cell Carcinoma
- Radiotherapy; Complications
- Radiotherapy
- +2 more
- (no location specified)
Sep 30, 2022
Obesity, Prediabetes Trial in La Jolla (Mirabegron)
Not yet recruiting
- Obesity, Prediabetes
-
La Jolla, CaliforniaUC San Diego Altman Clinical & Translational Research Institute
Nov 21, 2022
JAK-STAT Signaling Pathway in Pyoderma Gangrenosum
Not yet recruiting
- Pyoderma Gangrenosum
- +2 more
- immunohistochemical methods
- (no location specified)
Mar 21, 2022
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Biospecimen Collection, Follow-Up)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Biospecimen Collection
- Follow-Up
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas
Recruiting
- Esophagus Adenocarcinoma
- +2 more
-
Dallas, TexasDallas VA Medical Center
Nov 2, 2021
Basal Cell Carcinoma, Basal Cell Nevus Syndrome Trial in Australia (ASN-002)
Recruiting
- Basal Cell Carcinoma
- Basal Cell Nevus Syndrome
- ASN-002
-
Brisbane, Queensland, Australia
- +5 more
Feb 10, 2022
Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States
Not yet recruiting
- Esophageal Adenocarcinoma
- +2 more
-
Palo Alto, California
- +5 more
Jan 12, 2023
Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)
Not yet recruiting
- Metastatic Breast Cancer
- Breast Cancer
-
Houston, TexasM D Anderson Cancer Center
Feb 16, 2022
Carcinoma, Basal Cell Trial in Worldwide (cemiplimab)
Active, not recruiting
- Carcinoma, Basal Cell
-
Phoenix, Arizona
- +70 more
Jun 30, 2022
Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)
Completed
- Adult Acute Myeloid Leukemia in Remission
- Recurrent Adult Acute Myeloid Leukemia
-
Aurora, Colorado
- +1 more
Dec 30, 2021
VEGF-B Signaling Pathway in Obesity and Metabolic Disease
Completed
- Obesity
- Metabolic Disease
-
Wuhan, Hubei, ChinaDepartment of Endocrinology, Union Hospital,Tongji Medical Colle
Apr 5, 2021
Pancreatic Ductal Adenocarcinoma Trial in Spain (Gemcitabine, Nab paclitaxel, NLM-001)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Gemcitabine
- +3 more
-
Santiago De Compostela, A Coruña, Spain
- +5 more
Dec 5, 2022
Basal Cell Carcinoma Trial in Baltimore (Nivolumab, Ipilimumab, Relatlimab)
Recruiting
- Basal Cell Carcinoma
- Nivolumab
- +2 more
-
Baltimore, MarylandJohns Hopkins Hospital
Mar 10, 2022
Macrophages, GM-CSF and MARS Proteinosis
Recruiting
- Pulmonary Alveolar Proteinosis (PAP)
- +2 more
- Blood collection
- Bronchoalveolar lavage fluid collection
-
Paris, FranceHôpital Necker-Enfants Malades
Jun 26, 2021
NSCLC Trial in Dallas (Itraconazole)
Completed
- Non-small Cell Lung Cancer
-
Dallas, TexasUT Southwestern Medical Center
Apr 7, 2021
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh
Not yet recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Sep 8, 2022
Basal Cell Nevus Syndrome, Gorlin Syndrome Trial in Oakland, New York (GDC-0449)
Completed
- Basal Cell Nevus Syndrome
- Gorlin Syndrome
-
Oakland, California
- +1 more
Dec 16, 2020
Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma Trial in Bordeaux (Treatment with vismodegib)
Completed
- Metastatic Basal Cell Carcinoma
- Locally Advanced Basal Cell Carcinoma
- Treatment with vismodegib
-
Bordeaux, FranceChu de Bordeaux
Aug 17, 2022
JAK/STAT Pathway in Sarcoidosis Granuloma Cells
Recruiting
- Sarcoidosis
- JAK-STAT Pathway Deregulation
- Blood sample
-
Bobigny, FranceService de pneumologie Hôpital Avicenne
Oct 3, 2022
Solid Tumor, Adult, Hepatocellular Carcinoma Trial in Guangzhou (Combination of three inhibitors Trametinib, Everolimus and
Recruiting
- Solid Tumor, Adult
- Hepatocellular Carcinoma
- Combination of three inhibitors Trametinib, Everolimus and Lenvatinib
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Apr 7, 2021
CNS Lymphoma Trial in Beijing (Zanubrutinib)
Recruiting
- CNS Lymphoma
-
Beijing, Beijing, ChinaPeking University People's Hospital
Aug 1, 2022